Genetic testing can improve cardiovascular diagnosis, prognosis, and management
Invitae advantage
Genetic information impacts diagnosis, prognosis, and management
Quick reference guides and an overview video help identify candidates
A broad testing menu means we have the tests your patients need
Fast, affordable, high-quality genetic testing you can count on
DIAGNOSIS
|
|
PROGNOSIS
|
|
MANAGEMENT
|
|
Genetic testing is recommended by guidelines and consensus statements endorsed by professional societies including the American Association for Thoracic Surgery (AATS), American College of Cardiology (ACC), American Heart Association (AHA), Centers for Disease Control and Prevention (CDC), Heart Failure Society of America (HFSA), Heart Rhythm Society (HRS), and Pediatric & Congenital Electrophysiology Society (PACES).1-5
Test any number of cardiology genes for the same low price, and receive results in 14 days on average
Invitae testing is covered by many insurance plans; our $250 patient-pay option and patient assistance program help make high-quality testing accessible
Negative result? Test other cardiology genes at no additional charge
Positive result? Test blood relatives
Genetic counselors available on demand to help identify patients who could benefit from testing, discuss tough cases, and even counsel your patients directly
Invitae offers no-charge genetic testing to eligible patients at risk for hereditary ATTR amyloidosis through a partnership with Alnylam Pharmaceuticals.
Alnylam Act® for hereditary ATTR amyloidosis offers genetic testing at no charge for individuals (over 18 years of age) who may carry a genetic variant associated with hereditary ATTR (hATTR) amyloidosis, an inherited disease that is often misdiagnosed due to its constellation of symptoms.
Does my patient qualify?
|
1. Request free kits for collecting patient specimens
|
|
2. Order a test using Invitae’s HIPAA-compliant online portal or on paper
|
|
3. Receive an email when your results are ready (14 days on average)
|
References